Featured Research

from universities, journals, and other organizations

Investigational agent shows promise in reducing spread of prostate cancer

Date:
May 2, 2011
Source:
Georgetown University Medical Center
Summary:
A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, as seen in new lab studies.

A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, as seen in new lab studies say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center (GUMC).

Published online April 29 in PLoS ONE, the researchers report that if the agent continues to work well in further laboratory and preclinical studies, it may be the first prostate cancer drug specifically designed to stop cancer spread, or metastasis.

"This agent does not kill prostate cancer cells, but limits their ability to spread, which could be hugely beneficial in patients," says the study's lead investigator, Aykut άren, M.D., an associate professor at Georgetown Lombardi. "This study is an early proof of principle that such an approach might be feasible in the clinic, but we have a lot of work to refine and test the drug."

The agent, YK-4 279, was designed in the GUMC Drug Discovery Program, directed by Milton Brown, M.D., Ph.D., a co-author on the paper. YK-4 279 is also being investigated for the treatment of Ewing's sarcoma and is expected to move quickly into a clinical study. άren participated in the development of YK-4 279, an effort that was led by Georgetown Lombardi researcher Jeffrey Toretsky, M.D., also a co-author of this study.

Recent research has shown that 40 to 70 percent of prostate cancer cells express novel proteins when normal genes such as ETV1 and ERG break off from a chromosome and fuse in to a new location. These new genes produce proteins that push prostate cancer cells to become more aggressive and spread.

Noting that Ewing's sarcoma is produced by a similar fusion gene, the researchers decided to see if their drug would work in prostate cancer cells.

They applied the agent to prostate cancer cells with chromosomal translocations that expressed either an ERG protein or an ETV1 protein and found that the YK-4 279 did inhibit functions of these proteins, which reduced their motility and invasiveness. Tests in cancer cells that did not have either translocation show the agent had no effect.

The researchers also found that although the male hormone androgen turns on genes involved in progression of prostate cancer, including these fusions genes, the presence or absence of androgen is not necessary for this agent to work.

"That means, if successful, YK-4 279 could work in androgen sensitive prostate cancer cells or in cancer that has become resistant to androgen treatment," άren says.

He says the agent will likely need to be reformulated for prostate cancer use since the fusion gene that causes the Ewing's sarcoma is similar but not identical to ones in prostate cancer. 

The study was funded by Georgetown Lombardi's Cancer Center Support Grant from the National Cancer Institute, the Children's Cancer Foundation, Go4the Goal, Dani's Foundation, Alex's Lemonade Stand Foundation, Liddy Shriver Sarcoma Initiative, Burroughs Wellcome Clinical Scientist Award in Translational Research, and the National Institutes of Health.


Story Source:

The above story is based on materials provided by Georgetown University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Said Rahim, Elspeth M. Beauchamp, Yali Kong, Milton L. Brown, Jeffrey A. Toretsky, Aykut άren. YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion. PLoS ONE, 2011; 6 (4): e19343 DOI: 10.1371/journal.pone.0019343

Cite This Page:

Georgetown University Medical Center. "Investigational agent shows promise in reducing spread of prostate cancer." ScienceDaily. ScienceDaily, 2 May 2011. <www.sciencedaily.com/releases/2011/04/110429202240.htm>.
Georgetown University Medical Center. (2011, May 2). Investigational agent shows promise in reducing spread of prostate cancer. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2011/04/110429202240.htm
Georgetown University Medical Center. "Investigational agent shows promise in reducing spread of prostate cancer." ScienceDaily. www.sciencedaily.com/releases/2011/04/110429202240.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) — The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
Ebola Cases Could Reach 1.4 Million Within 4 Months

Ebola Cases Could Reach 1.4 Million Within 4 Months

Newsy (Sep. 23, 2014) — Health officials warn that without further intervention, the number of Ebola cases in Liberia and Sierra Leone could reach 1.4 million by January. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) — The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) — No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins